AIC
VOR icon

AWM Investment Company’s Vor Biopharma VOR Stock Holding History

AWM Investment Company’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,000
Closed -$665K – 129
2022
Q4 		$665K Buy
+5,000
New +$495K 0.1% 95

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

AWM Investment Company's VOR Position: Q1 2023 in Review

AWM Investment Company sold out of Vor Biopharma (VOR) in Q1 2023, closing a stake of 5,000 shares — an estimated $665K sold.

AWM Investment Company first reported a position in VOR in Q4 2022 and held it in 1 quarter. The position peaked at $665K in Q4 2022. 59 funds tracked by Wall St. Rank hold VOR as of Q1 2023.

  • AWM Investment Company reported no remaining Vor Biopharma position as of Q1 2023 after selling out during the quarter.
  • AWM Investment Company sold 5,000 Vor Biopharma shares in Q1 2023, an estimated $665K.
  • AWM Investment Company first reported a position in Vor Biopharma in Q4 2022 and held it in 1 quarter.
  • AWM Investment Company's Vor Biopharma position peaked at $665K in Q4 2022.
  • 59 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2023.

Based on AWM Investment Company's 13F filing for Q1 2023, filed 12 May 2023.